Teriflunomide

Table   Graphic     exposition period:

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Low birth weight (< 2500g)1.66 [0.49, 5.70]-1 study9823not evaluable ROB
Preterm (< 37 weeks)0.25 [0.01, 4.12]-1 study9423not evaluable ROB

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Caesarean1.01 [0.37, 2.74]-1 study25523not evaluable ROB

Neonatal disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Neonatal medical care0.50 [0.03, 8.44]-1 study4823not evaluable ROB

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Early intrauterine death (< 22 weeks)0.82 [0.20, 3.44]-1 study8147not evaluable ROB
Elective/induced termination of pregnancy4.97 [2.75, 8.99]-1 study23647not evaluable ROB
Late intrauterine deaths (> 22 weeks)1.56 [0.09, 27.10]-1 study1047not evaluable ROB
Therapeutic terminations of pregnancy1.57 [0.21, 11.93]-1 study2247not evaluable ROB

Hide endpoints reported in only one study ...